We are making collections of articles on the special issue Title “Medicine for Emerging Novel Coronavirus covid-19”.
An outbreak of the novel coronavirus, COVID-19, rapidly spread around the world in 2020. Currently, The virus, which emerged in the Chinese city of Wuhan in December, is a coronavirus and belongs to the same family as the pathogen that causes severe acute respiratory syndrome, or SARS. It causes a respiratory illness called COVID-19, which can spread from person to person.
Topics include but not limited to:
Novel coronavirus COVID-19 outbreak
COVID-19 and Patients with Chronic Kidney Disease
COVID-19 and Pregnant Patients
COVID-19 and Cardiovascular Disease
Patients Severe Acute Respiratory Syndrome (SARS)
COVID-19 and Patients With Cancer
COVID-19 Interactive Case SARS-CoV-2
Special issue articles can include both original unpublished research articles and review articles related to the specific theme.
Manuscripts will be accepted for publishing in the special issue only after getting approved by the peer review committee.
All the articles in special issues should strictly adhere to journal style and formatting.
Each special issue can be created with 5-7 articles.
Cardiology is a branch of medicine that deals with the disorders of the heart as well as some parts of the circulatory system. The field includes medical diagnosis and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease and electrophysiology. Physicians who specialize in this field of medicine are called cardiologists, a specialty of internal medicine. Pediatric cardiologists are pediatricians who specialize in cardiology.
Covid-19 has been marked as a highly pathogenic coronavirus of COVID-19 disease into the human population, causing over 5.5 million confirmed cases worldwide. As COVID-19 has represented a worldwide danger with critical human setbacks and extreme monetary misfortunes, there is a squeezing interest to additionally comprehend the current circumstance and create sane techniques to contain the intense spread of the infection. In spite of the fact that there are no particular antiviral treatments that have demonstrated viable in randomized clinical preliminaries, right now, the fast identification innovation alongside a few promising therapeutics for COVID-19 have moderated its radical transmission. In addition, worldwide foundations and enterprises have initiated to parse out viable immunizations for the counteraction of COVID-19. Thus, the current audit will give thorough subtleties of broad investigates concerning the medication disclosure and helpful choices for COVID-19 just as some keen conversations of the situation with COVID-19.